177 related articles for article (PubMed ID: 24908063)
1. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review.
Zhang J; Ma L; Xie Z; Guo Y; Sun W; Zhang L; Lin J; Xiao J; Zhu Y; Tian Y
Med Oncol; 2014 Jul; 31(7):32. PubMed ID: 24908063
[TBL] [Abstract][Full Text] [Related]
2. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
3. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
4. Special malignancy pattern in Chinese renal transplantation recipients: a single center experience and literature review.
Sun Q; Li X; Cheng D; He Q; Chen J; Ji S; Liu Z
Asian Pac J Cancer Prev; 2011; 12(12):3347-51. PubMed ID: 22471478
[TBL] [Abstract][Full Text] [Related]
5. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
6. The benefits of cancer screening in kidney transplant recipients: a single-center experience.
Kato T; Kakuta Y; Abe T; Yamanaka K; Imamura R; Okumi M; Ichimaru N; Takahara S; Nonomura N
Cancer Med; 2016 Feb; 5(2):153-8. PubMed ID: 26686199
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Incidence of Malignancy After Kidney Transplant in Mainland China: A Single-Center Analysis.
Liu D; Quan X; Ji H; Xing X; Zhou C; Jing F
Exp Clin Transplant; 2022 Jun; 20(6):558-563. PubMed ID: 35791829
[TBL] [Abstract][Full Text] [Related]
8. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing characteristics of urothelial carcinoma in kidney transplant recipients between China and Western countries.
Liu GM; Fang Q; Ma HS; Sun G; Wang XC
Transplant Proc; 2013; 45(6):2197-202. PubMed ID: 23747184
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.
Nejatifar F; Monfared A; Khosravi M; Lebadi M; Shakiba M; Mokhtari G; Aghajanzadeh P; Haghdar-Saheli Y; Movasaghi A; Ramezanzadeh E; Akhondzadeh L
Iran J Kidney Dis; 2020 Dec; 14(6):439-447. PubMed ID: 33277447
[TBL] [Abstract][Full Text] [Related]
11. Malignancy in renal transplant recipients: a single-center experience in Thailand.
Ruangkanchanasetr P; Lauhawatana B; Leawseng S; Kitpanich S; Lumpaopong A; Thirakhupt P
J Med Assoc Thai; 2012 May; 95 Suppl 5():S12-6. PubMed ID: 22934439
[TBL] [Abstract][Full Text] [Related]
12. Malignancies in organ transplant recipients.
Hoshida Y; Aozasa K
Pathol Int; 2004 Sep; 54(9):649-58. PubMed ID: 15363032
[TBL] [Abstract][Full Text] [Related]
13. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
Akbarzadehpasha A; Oliaei F; Asrari MR; Alizadeh-Navaei R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
[TBL] [Abstract][Full Text] [Related]
14. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
[TBL] [Abstract][Full Text] [Related]
15. Malignancy after renal transplantation: a single-center experience.
Vrotniakaite K; Jaceviciute R; Rudminiene I; Laucyte-Cibulskiene A; Rainiene T; Jankevicius F; Zelvys A; Miglinas M
Ann Transplant; 2014 Sep; 19():456-63. PubMed ID: 25223375
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
[TBL] [Abstract][Full Text] [Related]
18. Kidney Transplant Recipients Have Higher Malignancy Prevalence Than Hemodialyzed Patients.
Pyrża M; Małyszko J; Głogowski T; Wieliczko M; Żebrowski P; Małyszko J
Transplant Proc; 2022 May; 54(4):972-975. PubMed ID: 35282885
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study.
Jung SW; Lee H; Cha JM
BMC Nephrol; 2022 Apr; 23(1):160. PubMed ID: 35484531
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study.
Hsiao FY; Hsu WW
Int Urol Nephrol; 2014 Apr; 46(4):833-8. PubMed ID: 24009082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]